2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement 
Halberd Eliminates E. Coli in 20 Minutes Vs. 7-10 Days with Conventional Antibiotics
Jackson Center, Pennsylvania--(Newsfile Corp. - April 18, 2022) - Halberd Corporation (OTC PINK: HALB) demonstrated the efficacy of its patented...
New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond
Masimo SafetyNet® Reduced Mortality Among COVID-19 Patients IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a Viewpoint article...
Blue Spark Technologies Raises $40 Million in Growth Funding Led by Ghost Tree Partners to Advance AI-Based Remote Patient Monitoring
Funding will accelerate company’s growth and widespread adoption of continuous wearable remote patient monitoring solutions CLEVELAND--(BUSINESS WIRE)--Blue Spark Technologies, Inc.,...
CENTR Brands Corp. Closes Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2022) - CENTR Brands Corp. (CSE: CNTR) (FSE: 303) (OTCQB: CNTRF) (the "Company")...
Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
SAN FRANCISCO, CA / ACCESSWIRE / April 15, 2022 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") announced today...
ESO Releases 2022 ESO Fire Service Index to Explore Key Trends and Measures Affecting Fire Departments Across the Country
Index looks at response time, structures involved in fires, property loss and decontamination AUSTIN, Texas--(BUSINESS WIRE)--ESO, the leading data and...
MaxCyte Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GAITHERSBURG, Md., April 15, 2022 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT, MXCN), a leading commercial cell-engineering company...
TG Therapeutics Announces Voluntary Withdrawal of the BLA/sNDA for U2 to Treat Patients with CLL and SLL
Company voluntarily withdraws UKONIQ® from sale for approved indications of relapsed/refractory MZL and FL Company to host conference call, Monday,...
2022 first quarter : Income increase by 55%
Press Release Ecully, April 15, 2022 – 10 am Continued growth in Q1 2022Q1 2022 revenues up +55% In thousands of...
Immunicum AB: Immunicum AB (publ) Publishes the Annual Report for 2021
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, today announced...
EssilorLuxottica: Leadership changes announced at GrandVision
Leadership changes announced at GrandVision Charenton-le-Pont, France, and Schiphol, The Netherlands (April 15, 2022 – 8 am CET) – EssilorLuxottica...
Koelis Announces Completes of €10 Million Follow-On Growth Equity Financing with InnovaHealth Partners
GRENOBLE, France and PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”) announced today the...
LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market
PASADENA, CA, April 14, 2022 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage drug discovery company developing...
Sienna Announces First Quarter 2022 Results Release Date and Conference Call
MARKHAM, Ontario, April 14, 2022 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) announced that...
Christina Lake Cannabis Corp. Files Financial Statements for the Year Ended November 30, 2021
VANCOUVER, British Columbia, April 14, 2022 (GLOBE NEWSWIRE) -- (CSE: CLC) -- Christina Lake Cannabis Corp. (the “Corporation or “Christina...
Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2022
Monthly information regarding the total number of voting rights and total number of shares of the Company as...
Pasithea Therapeutics to Present at the NobleCon18 Investor Conference 2022
MIAMI BEACH, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel...
CytomX Therapeutics Announces Retirement of John A. Scarlett, M.D. from Board of Directors
SOUTH SAN FRANCISCO, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field...
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
PONTE VEDRA, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company...
Vor Bio Announces Retirement of Chief Medical Officer
CAMBRIDGE, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today...